Unimolecular integration of NMDA receptor antagonism with GLP-1 receptor agonism effectively reverses obesity, hyperglycaemia and dyslipidaemia in rodent models of metabolic disease. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.